Developing new methods to create complex molecules using copper catalysts
New Strategies for Copper-Catalyzed Cross-Coupling of Alkyl Electrophiles
This study is looking at new ways to use copper to help create important small molecules that can lead to better medicines and treatments for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Cincinnati NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-11077801 on NIH RePORTER |
What this research studies
This research focuses on creating innovative copper-catalyzed reactions to synthesize complex bioactive small molecules, which are essential for pharmaceuticals and agrochemicals. By utilizing copper as a catalyst, the project aims to improve the efficiency of forming carbon-carbon and carbon-heteroatom bonds, which are crucial in organic chemistry. The researchers will explore the mechanisms of these reactions to enhance their effectiveness and overcome existing limitations. Patients may benefit indirectly through the development of new medications and treatments derived from these complex molecules.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals who require new treatment options for diseases that currently have limited therapeutic alternatives.
Not a fit: Patients with conditions that are not addressed by new pharmaceutical developments or those not involved in agricultural chemical applications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and more effective medications and agricultural products.
How similar studies have performed: Previous research has shown promise in using copper-catalyzed reactions for similar applications, indicating a potential for success in this novel approach.
Where this research is happening
Cincinnati, United States
- University of Cincinnati — Cincinnati, United States (Active)
Researchers
- Principal investigator: Liu, Wei — University of Cincinnati
- Study coordinator: Liu, Wei
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.